Guqi Wang

1.3k total citations
30 papers, 1.1k citations indexed

About

Guqi Wang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Guqi Wang has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Guqi Wang's work include Drug-Induced Hepatotoxicity and Protection (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Guqi Wang is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Guqi Wang collaborates with scholars based in Canada, United States and China. Guqi Wang's co-authors include Frank J. Burczynski, Herbert L. Bonkovsky, Yuewen Gong, Michael S. Roberts, Judy E. Anderson, Brian B. Hasinoff, Gerald Y. Minuk, Leonard B. Seeff, Lingyi Zhang and Guangming Zhong and has published in prestigious journals such as Gastroenterology, Hepatology and Analytical Biochemistry.

In The Last Decade

Guqi Wang

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guqi Wang Canada 17 454 310 165 142 118 30 1.1k
Kenji Takemoto Japan 24 408 0.9× 234 0.8× 95 0.6× 230 1.6× 110 0.9× 86 1.4k
Bassem Refaat Saudi Arabia 24 263 0.6× 149 0.5× 106 0.6× 114 0.8× 50 0.4× 88 1.5k
A. Eric Schultze United States 22 406 0.9× 144 0.5× 202 1.2× 102 0.7× 109 0.9× 67 1.4k
Yunhuan Liu China 22 846 1.9× 480 1.5× 134 0.8× 286 2.0× 170 1.4× 46 2.0k
Chie Aoki Japan 22 260 0.6× 158 0.5× 162 1.0× 44 0.3× 106 0.9× 46 1.0k
Marieke H. Schoemaker Netherlands 17 367 0.8× 403 1.3× 148 0.9× 203 1.4× 172 1.5× 29 1.3k
Xiaoyuan Bian China 20 985 2.2× 311 1.0× 143 0.9× 170 1.2× 74 0.6× 33 1.5k
Trần Thị Hiền South Korea 24 901 2.0× 320 1.0× 112 0.7× 205 1.4× 26 0.2× 69 1.9k
Jong-Won Kim South Korea 13 227 0.5× 218 0.7× 137 0.8× 72 0.5× 64 0.5× 29 674

Countries citing papers authored by Guqi Wang

Since Specialization
Citations

This map shows the geographic impact of Guqi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guqi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guqi Wang more than expected).

Fields of papers citing papers by Guqi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guqi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guqi Wang. The network helps show where Guqi Wang may publish in the future.

Co-authorship network of co-authors of Guqi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Guqi Wang. A scholar is included among the top collaborators of Guqi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guqi Wang. Guqi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Guqi, et al.. (2019). The Role of Traditional Chinese Medicines (TCM) and Other Complementary and Alternative Medicines (CAM) in the Management of Chronic Hepatitis B. Current Hepatology Reports. 18(3). 316–321. 3 indexed citations
2.
Ma, Junli, Shan Zeng, Yan Zhang, et al.. (2017). BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma. Cancer Letters. 411. 117–129. 67 indexed citations
3.
Zeng, Shan, Yan Zhang, Junli Ma, et al.. (2017). BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial–mesenchymal transition via upregulating ID2. Cancer Letters. 390. 67–76. 35 indexed citations
4.
Chen, Yufei, Wei Li, Guqi Wang, & Frank J. Burczynski. (2017). Clofibrate Attenuates ROS Production by Lipid Overload in Cultured Rat Hepatoma Cells. Journal of Pharmacy & Pharmaceutical Sciences. 20(0). 239–239. 3 indexed citations
5.
Wang, Guqi, et al.. (2015). Recent insights into the biological functions of liver fatty acid binding protein 1. Journal of Lipid Research. 56(12). 2238–2247. 178 indexed citations
6.
Seeff, Leonard B., Herbert L. Bonkovsky, Victor J. Navarro, & Guqi Wang. (2014). Herbal Products and the Liver: A Review of Adverse Effects and Mechanisms. Gastroenterology. 148(3). 517–532.e3. 90 indexed citations
7.
Wang, Guqi, et al.. (2014). Hepatoprotective role of liver fatty acid binding protein in acetaminophen induced toxicity. BMC Gastroenterology. 14(1). 44–44. 15 indexed citations
8.
Wang, Guqi, Lingyi Zhang, & Herbert L. Bonkovsky. (2012). Chinese medicine for treatment of chronic hepatitis B. Chinese Journal of Integrative Medicine. 18(4). 253–255. 19 indexed citations
9.
Gong, Yuewen, et al.. (2010). Regulation of liver fatty acid binding protein expression by clofibrate in hepatoma cells. Biochemistry and Cell Biology. 88(6). 957–967. 7 indexed citations
10.
Gong, Yuewen, et al.. (2009). Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity. Journal of Lipid Research. 50(12). 2445–2454. 45 indexed citations
11.
Zhang, Lingyi, et al.. (2009). Contemporary Clinical Research of Traditional Chinese Medicines for Chronic Hepatitis B in China: An Analytical Review. Hepatology. 51(2). 690–698. 98 indexed citations
12.
Wang, Guqi, et al.. (2008). Cell lysis with dimethyl sulphoxide produces stable homogeneous solutions in the dichlorofluorescein oxidative stress assay. Free Radical Research. 42(5). 435–441. 44 indexed citations
13.
Wang, Guqi, Hong Shen, Ganesh Rajaraman, et al.. (2007). Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats. European Journal of Pharmacology. 560(1). 61–68. 45 indexed citations
14.
Rajaraman, Ganesh, et al.. (2007). Effect of diltiazem isomers and thiamine on piglet liver microsomal peroxidation using dichlorofluorescein.. PubMed. 10(3). 380–7. 4 indexed citations
15.
Wang, Guqi, Yuewen Gong, Judy E. Anderson, et al.. (2005). Antioxidative Function of L-FABP in L-FABP Stably Transfected Chang Liver Cells *. Hepatology. 42(4). 871–879. 136 indexed citations
16.
Wang, Guqi, et al.. (2004). Enhanced expression of cytosolic fatty acid binding protein and fatty acid uptake during liver regeneration in rats. Molecular and Cellular Biochemistry. 262(1-2). 41–49. 23 indexed citations
17.
She, Yi‐Min, Guqi Wang, Alexander Loboda, et al.. (2002). Sequencing of rat liver cytosolic proteins by matrix-assisted laser desorption ionization–quadrupole time-of-flight mass spectrometry following electrophoretic separation and extraction. Analytical Biochemistry. 310(2). 137–147. 14 indexed citations
18.
Wang, Guqi, Frank J. Burczynski, Brian B. Hasinoff, & Guangming Zhong. (2002). Infection of myocytes with chlamydiae. Microbiology. 148(12). 3955–3959. 29 indexed citations
19.
Burczynski, Frank J., et al.. (1999). Altered transmembrane ionic flux in hepatocytes isolated from cirrhotic rats. Journal of Hepatology. 30(3). 492–497. 5 indexed citations
20.
Burczynski, Frank J., Guqi Wang, & Mark Hnatowich. (1997). Effect of binding protein surface charge on palmitate uptake by hepatocyte suspensions. British Journal of Pharmacology. 120(7). 1215–1220. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026